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THE IMPACT OF KETOGENIC DIET ON CEREBRAL EXCITABILITY 
IAN BENJAMIN 
 
ABSTRACT 
Many neurological disorders are a result of widespread changes in the excitability of 
brain tissue. The specific changes in neuronal excitability produces or worsens many of 
the symptoms associated with these disorders. Pharmacological methods are effective, 
but their associated side-effects are substantial, and often approximate the severity of the 
symptoms of the original disorder. The ketogenic diet, a high-fat, low-carbohydrate diet, 
has been shown to improve many neurological diseases by reducing hyperexcitability 
without the aforementioned side effects.  The current study tested the hypothesis that a 
ketogenic diet would be associated with alterations in cerebral excitability. 
Animals were fed either a control or ketogenic diet for at least 21 days prior to 
experimentation. Power spectral analysis was conducted using EEG data across 
frequency bands, and compared between diet groups. Current source density analysis was 
also performed to visualize potential alterations in cerebral excitability. In the second part 
of the experiment, a non-invasive ischemic stroke was delivered, and the excitability of 
the contralateral cortex was monitored.  
No significant differences were observed between ketogenic and control experiments in 
regards to overall excitability, although ketogenic diet experiments showed a 
		 vii 
significantly higher number of acute EEG depressions. No cortical spreading depression 
events were observed in contralateral recordings. Our findings are in contrast with data 
showing that ketogenic diets change overall basal excitability, but are in concert with 
other studies that show that ketogenic diets may not be associated with changes in 
excitability, but in changes in neuroplasticity.  
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INTRODUCTION 	
Modulating Brain Activity 
Neurological diseases negatively affect activities of daily living by impairing 
brain activity and thereby producing functional deficits. Many neurological disorders are 
a result of widespread changes in the excitability of brain tissue.  For example, epilepsy is 
a disorder that lowers neuronal thresholds for excitation, which manifests in seizures 
(Badawy, Vogrin, Lai, & Cook, 2013). Parkinson’s disease is characterized by an overall 
decrease in cerebral excitability, which manifests in ataxia, initiation tremors, and 
memory impairment (Suzuki, 2014). Changes in cerebral activity are also seen in stroke, 
Attention Deficit-Hyperactivity Disorder (ADHD), Alzheimer’s, depression, and even 
eating disorders such as anorexia (Khedr, El Fetoh, El Bieh, Ali, & Karim, 2014). The 
specific changes in neuronal excitability produces or worsens many of the symptoms 
associated with these disorders. Pharmacological agents are most frequently used to treat 
or control the symptoms of these disorders, although brain stimulation techniques have 
recently gained attention in the medical community (Stypulkowski, Stanslaski, Jensen, 
Denison, & Giftakis, 2014). While both of these methods are effective, their associated 
side-effects are substantial, and ofttimes can approximate the severity of the symptoms of 
the original disorder. Phenobarbital, which is one of the most widely used 
pharmaceuticals for epilepsy, often produces sleepiness, dizziness, memory problems, 
and depression in patients (Elafros, Bui, & Birbeck, 2014). Pharmaceutical compounds 
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are often prohibitively expensive, and may not be the preferred means of treatment by 
patients (Linsky, Simon, & Bokhour, 2015).  
Another way by which brain activity can be controlled is through an alteration in 
diet. This approach consistently produces few to no side-effects, and has been shown to 
be beneficial in producing lasting alterations in cerebral excitability (Masino, Kawamura 
Jr., Ruskin, Geiger, & Boison, 2012). Diet-manipulation is also more cost-effective, and 
culturally flexible. 
The goal of this thesis is to test the effect of a specific diet on cerebral 
excitability. To understand how brain activity changes in a disease state, it is necessary to 
understand basic brain metabolism. From there, the introduction will discuss how 
changes in nutrition can produce changes in excitability, and promote recovery in 
neurological disorders. 
Brain as a metabolic organ  
The brain is unique as it represents only 2% of total body mass, but accounts for 
20-25% of the total energy consumption (Bélanger, Allaman, & Magistretti, 2011). It is 
the most energetically expensive organ in the body per unit weight, and preferentially 
uses glucose to fuel its cellular processes as opposed to fat. Even though the brain 
requires a constant source of energy, it does not convert stores of fat, glycogen or protein 
into glucose. The brain has the ability to sense and regulate blood glucose levels, with 
regions in the hypothalamic paraventricular and arcuate nuclei, and the nucleus tractus 
solitarius in the brain stem most integral for this function (Ogunnowo-Bada, Heeley, 
Brochard, & Evans, 2014). Such sensing is thought to be metabolic and non-metabolic in 
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nature. Metabolic sensing implies that the entry and metabolism of glucose in a neuron 
serves as the signal. Non-metabolic signaling could be mediated by activity of ATP-gated 
potassium channels (Katp), or linked to the activity of active glucose transporters in 
astrocytes and neurons (Ogunnowo-Bada, Heeley, Brochard, & Evans, 2014). Katp 
channels are also widely implicated in serving as a link between glucoregulation and 
neuroprotection (McCrimmon et al., 2005), and will be discussed later in this paper.  
As seen in figure 1, glucose normally enters the neuronal cell through a GLUT-2 
transporter and undergoes glycolysis in the cytoplasm to produce pyruvate. Pyruvate is 
transported into the mitochondria where it is converted into acetyl-CoA. Acetyl-CoA 
enters the citric acid cycle, producing intermediates to be used for oxidative 
phosphorylation. The end result is the production of ATP, which is the primary chemical 
energy source of the cell. 
In periods of prolonged hypoglycemia, the brain uses intermediates of fat 
metabolism for energy. As triglyceride stores are larger than glycogen stores, and fat 
provides more kcal of energy per gram than does carbohydrate, this alternate method of 
energy production is very efficient. These metabolites also have the benefit of entering 
the mitochondria directly as shown in figure 1. Although this alternate form of 
metabolism is more efficient, cerebral tissue strongly prefers glucose for its metabolic 
demands (Harvey & Ferrier, 2011). 
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Figure 1: Visualization of the two energetic pathways in a neuron. A neuron that 
relies upon glucose metabolism must convert glucose into pyruvate. Pyruvate will be 
transported into the mitochondria, and enter the citric acid (TCA) cycle for ATP 
production. Glucose enters the cell through a GLUT-2 transporter. Ketone bodies enter 
the neuron through monocarboxylic acid transporters (MCT) which will be discussed 
later in the introduction. Once inside the neuron, the ketone bodies can directly enter the 
mitochondria for metabolism. Figure taken from (Lutas & Yellen, 2013). 
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 Magnetic resonance spectroscopy utilizes radiolabeled carbon to visualize glucose 
oxidation and the rate of glutamate and GABA recycling in neurons and astrocytes. Using 
this technique, it has been estimated that 80% of brain energy demands are related to 
processes that support neuronal firing and cycling of neurotransmitters (Shulman, 
Rothman, Behar, & Hyder, 2004). The specific processes are the establishment and 
maintenance of ion-gradients through ATP-coupled ion pumps, as well as the 
manufacturing and recycling of neurotransmitters (Alle et al., 2009). Diets that more 
effectively funnel substrates into the citric acid cycle could improve the efficiency of 
these processes, especially if those diets improve energetics in periods of hypoxia. High-
fat, low-carbohydrate diets are thought to do just that, an example of which is the 
ketogenic diet.  
 
Ketones and the Ketogenic Diet 	
A ketone is an organic compound with the chemical formula RC(=O)R’, where 
the carbonyl carbon is directly attached to a carbon molecule in R and R’. A ketone is 
generally acidic with a pKa of approximately 4, which is why ketone bodies are also 
called keto-acids.  
As a general guideline, a traditional ketogenic diet (KD) has a fat to carb/protein 
ratio of 4:1. This ratio is not strictly defined, and can be modified to whatever keeps 
ketone body concentrations sufficiently elevated. Protein intake recommendations are 
flexible, but normally account for 10-30% of calories (Lutas & Yellen, 2013). The major 
energy source of ketogenic diets are metabolites called ketone bodies, are produced by 
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the liver, and come in one of three water-soluble forms. They are acetone, acetoacetate 
(AcAc), and beta-hydroxybutyrate (ß-OHB). These metabolites are produced from fatty 
acid oxidation. Free fatty acids (FFA) broken down from triglyceride in adipose tissue are 
transformed into the ketone bodies AcAc and ß-OHB in the liver by the enzymes HMG-
CoA lyase and ß-OHB dehydrogenase, respectively (Harvey & Ferrier, 2011). The 
conversion of acety-CoA obtained from fatty acid oxidation into ketone bodies is 
accomplished entirely in the mitochondria, and is a process known as ketogenesis. 
Ketone bodies are then transported to extra-hepatic tissues with the necessary enzymes 
for reconversion into Acetyl-CoA. Acetyl-CoA can then enter the mitochondria to 
complete the TCA cycle as usual. This process is depicted below.
 
 
Figure 2. Endogenous Ketogenic Pathway. FFAs broken down from TG in adipose 
tissue are transformed into the ketone bodies ß-OHB and AcAc in the liver. 
Subsequently, these substances are transported to extra-hepatic tissues in possession of 
the necessary enzymes for reconversion into Acetyl-CoA. Acetyl-CoA can then enter the 
mitochondria to complete the TCA cycle as usual. Figure taken from (Harvey & Ferrier, 
2011). 
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When ketone bodies are chronically elevated and glucose is depleted, the body 
uses them as energy substrates in a state known as ketosis. 
For a tissue to successfully utilize ketone bodies for energy, it must be able to 
convert ketone bodies to acetyl-CoA. Thiophorase, or succinyl-CoA:acetoacetate-CoA 
tranferase is the enzyme that determines this. It reconverts the products of fat breakdown, 
acetoacetate (AcAc) and succinyl-CoA, into the products acetoacetyl-CoA and succinate. 
Thiolase subsequently converts acetoacetyl-CoA into acetyl-CoA for entry into the TCA 
cycle, which, as mentioned earlier provides substrates necessary for energy production. 
Because the liver lacks thiophorase, it cannot use ketone bodies as fuel substrates. Since 
the brain does possess thiophorase, it gains the metabolic flexibility to use ketone bodies 
as energy sources during hypoglycemia. 
Ketosis typically occurs during prolonged periods of starvation, beginning around 
24 days without food as seen in figure 3. 
 
Figure 3. Metabolic changes induced during starvation. Figure taken from (Cahill, 
2006). 
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This process can also be achieved amidst normal caloric intake by maintaining a 
very high fat and very low carbohydrate intake (Cahill, 2006). Ketone body concentration 
will reach sufficient concentrations for metabolism at approximately 3 weeks of 
starvation, or 3 weeks of a proper KD. 
Fat intake needs to be sufficiently high to provide enough substrate for 
ketogenesis, and glucose intake needs to be kept low enough to suppress insulin release. 
Insulin is released with increases in blood glucose concentrations, helps shuttle blood 
glucose into cells for metabolism, and potently inhibits fatty acid oxidation (Harvey & 
Ferrier, 2011). This leads to a reduction of ketogenic metabolism. Lastly, protein 
consumption needs to be monitored, as proteins can be converted into glucose and trigger 
insulin release. For example, certain amino acids such as leucine can trigger potent spikes 
in insulin levels (Harvey & Ferrier, 2011).  
There is some concern that KD could lead to acidification of the blood due to the 
changes seen in uncontrolled diabetes. In diabetes, the body is non-responsive to the 
hormone insulin (Harvey & Ferrier, 2011).  Because insulin cannot effectively shuttle 
glucose into cells, the body reacts as though it was starving. The result is an elevation in 
fatty acid breakdown, and elevation of ketone body concentration in the blood. These 
keto-acids account for the acidification of blood in uncontrolled diabetes. As depicted on 
the following page in table 1, studies investigating ketogenic acidosis found no changes 
in blood pH of healthy subjects, suggesting that these diets should not be a concern for 
patients with disorders of the brain only (Paoli, Rubini, Volek, & Grimaldi, 2013).  
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Table 1: Blood pH levels associated with normal, high-carbohydrate diets vs 
controlled ketogenic diets vs diabetic ketoacidosis. pH levels are unsignificantly 
different between healthy subjects regardless of diet. Table taken from Paoli, Rubini, 
Volek, & Grimaldi, 2013. 
 
	
In addition to possessing the correct enzymes necessary for reconverting ketone 
bodies into acetyl-CoA, a tissue must first absorb the ketone bodies from the blood 
stream. For most organs this is not a problem, as the blood supply is not filtered prior to 
arriving at the tissue. But the brain is unique in that is has a protective barrier between the 
blood and the CSF, known as the blood brain barrier (BBB).  
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Figure 4. Cross section of a brain microvessel. Endothelial cells are ensheathed by the 
basal lamina which contains pericytes. Astrocytic endfeet are connected to the basal 
lamina, and are in contact with glia and neuronal brain tissue. Figure taken from 
(Mahringer, Ott, & Fricker, 2013) 
 
Shown in figure 4, the BBB is a highly selective, semi-permeable barrier that 
separates blood from brain tissue. For the brain tissue to utilize a given substance, the 
compound must pass through the BBB. Ketones are too polar and too large to diffuse 
across the BBB, and require the action of specialized transporters known as 
monocarboxylic-acid transporters (MCT).  
There are two types of these transporters, MCT1 and MCT2, both of which are 
present in vascular and non-vascular tissue, and in neuronal and non-neuronal tissue 
(Prins, 2008). These transporters are responsible for the transport of ketone bodies into all 
tissues. A neuronal MCT transporter can be seen in figure 1. Not pictured are MCTs on 
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astrocytes and endothelial cells. Under conditions of high glucose intake, the expression 
of these two transporters in astrocytes, endothelial cells, and neurons is relatively 
constant. If a KD is employed, as shown by Moore in 1976, the expression and activity of 
these transporters changes depending upon concentration and the identity of fuel 
substrates present, respectively. As a result, even if the concentration of ketone bodies 
does not change over the course of 1 week, the activity of MCT1 and MCT2 will still 
increase due to the activating presence of ketones themselves. Increased MCT1 and 
MCT2 expression results in better ketone body uptake, and more substrate availability for 
metabolism as shown in table 2. In a state of ketosis, brain ketone metabolism is limited 
by the cerebral uptake of ketone bodies, not by the activity of thiolase or thiophorase 
(Prins 2008). 
 
Table 2. MCT Levels following CNS injury. Figure taken from (Prins, 2008) 
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Metabolic Changes of Stroke 
Ketogenic diets have been shown to reduce hyperexcitability in the brain, gaining 
importance in the context of neurological diseases like stroke, in which excitability is 
heightened. 
A neuronal ischemic event occurs when a blood clot from the peripheral or central 
blood vessels lodges and occludes blood flow in a cerebral artery. The result is a 
stereotypic cascade characterized by a drop in ATP stores, a loss of ionic homeostasis, 
intracellular lactate accumulation, and extracellular glutamate accumulation (Iadecola & 
Anrather, 2011). It is hypothesized that the Na+/K+ ATPase pump malfunctions due to the 
loss of ATP, leading to an accumulation of K+ outside of the neuron, thereby triggering 
Na+ and Ca++ cytoplasmic influx. This influx leads to a massive release of excitatory 
glutamate and prolonged stimulation of AMPA and NMDA ionotropic receptors 
(Moskowitz, Lo, & Iadecola, 2010). The stimulation of these receptors triggers further 
Ca+, Na+, and water influx into neurons. Furthermore, glutamate recycling is impeded 
due to the loss of ATP, as illustrated in figure 5 on the following page.   	
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Figure 5: Astrocyte mediated glutamate recycling. Following glutamate release, 
recycling of the neurotransmitter is accomplished with the assistance of neighboring 
astrocytes. These astrocytes utilize the electrochemical gradient of Na+ maintained by the 
Na/K ATPase as a driving force, and glutamine synthetase to interconvert glutamate to 
glutamine. Thus, Na uptake and glutamate recycling are tightly coupled. Additionally, 
astrocytic glutamate is converted into glutamine by glutamine synthetase, released into 
the synaptic cleft, reuptaken by the neuron, and reconverted into glutamate for future 
release. This conversion also requires energy derived from ATP. This presents a problem 
seen in cerebral ischemia, in which oxygen levels drop and ATP production cessates. In 
this scenario, insufficient ATP is produced to power either the Na/K ATPase pump or 
glutamine synthetase, and as a result, the Na gradient is disrupted and glutamate 
accumulates in the cleft. Figure taken from (Magistretti, Pellerin, Rothman, & Shulman, 
1999). 
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The accumulation of intracellular Ca++ triggers calcium-dependent proteases such 
as caspases to produce free radicals, vasodilatory NO, and arachidonic acid metabolites. 
If the cascade is not interrupted, caspase-dependent apoptosis is initiated, resulting in cell 
death and necrosis.  
 
KD relevance to excitability 
All of these aforementioned cellular changes should amount to elevated brain 
activity. The idea behind KD is that they provide an alternative means for energy 
production in an anaerobic environment. By maintaining ion-flux and glycolytic stability 
amidst cerebral injury, the KD should antagonize [1]changes in neuronal membrane 
potentials, and thus, mitigate changes in cerebral excitability.   	
Ketogenic diets have not been shown to alter homeostatic concentrations of 
intracellular and extracellular ions (Hartman, Gasior, Vining, & Rogawski, 2007), but 
they have been postulated to change ion channel permeability. For example, ß-OHB 
administration reduced Ca++ entry following neuronal NMDA activation (Lund, Ploug, 
Iversen, Jensen, & Jansen-Olesen, 2015). Given that intravenous ß-OHB administration 
after an ischemic event reduced cerebral infarct volume by 50% (Prins, 2008), the KD 
alteration of Ca++ influx is of interest. 
Recent studies support that Ca++ influx can occur via glutamate independent acid-
sensing ion channels (ASICs). These channels are sensitive to intracellular acidification 
seen during anaerobic glycolysis, and have been shown to trigger intracellular calcium 
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flux independently of glutamate (Simon & Xiong, 2006). Not only does anaerobic 
glycolysis produce acid, it produces lactate. It has recently been shown that lactate is one 
of the most important enhancers of ASIC function (Wang & Xu, 2011). 
Similarly, ATP-sensitive K+ channels have been characterized in both neurons 
and glial cells, and serve as molecular sensors of cellular metabolism (Nichols, 2006). 
Katp channels are located on both the neurolemma and the mitochondrial membrane, and 
are thought to open when the ATP/ADP ratio is reduced. K+ efflux hyperpolarizes the 
cell, reducing the probability of cytosolic Ca++ influx from voltage-gated Ca++ channels 
(Akrouh, Halcomb, Nichols, & Sala-Rabanal, 2009). The relationship between KD and 
Katp is paradoxical, as a boost in ATP from KD should inhibit these channels, not activate 
them as has been observed. To reconcile this, it has been shown that the glycolytic 
enzyme glyceraldehyde 3-phosphate dehydrogenase directly regulates Katp channel 
activity, suggesting that our understanding of Katp permeability is incomplete (Lund, 
Ploug, Iversen, Jensen, & Jansen-Olesen, 2015). High ATP levels obtained through a 
ketogenic diet should suppress glycolytic flux, as ATP and the citric acid cycle 
intermediate citrate are feedback inhibitors of glycolysis. It is also hypothesized that 
polyunsaturated fatty acids obtained through the KD may also activate Katp channels, 
albeit indirectly (McCrimmon et al., 2005). It was shown that fatty acids intercalated in 
neuronal membranes strongly interacted with Katp channels, and potently reduced their 
affinity for ATP (Shyng & Nichols, 1998). The apparent paradox between ketosis and 
activation of Katp channels may be due to an incomplete understanding of the channel’s 
kinetics, and warrants further investigation. 
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 While the glucose-dependent brain increases anaerobic glycolysis in the face of 
hypoxia, the ketogenic brain is able to significantly bypass glycolysis. To support this, 
the administration of ß-OHB reduces neuronal glycolytic rate in normoxic conditions 
(Lund, Ploug, Iversen, Jensen, & Jansen-Olesen, 2015). If the aforementioned hypotheses 
surrounding ASICs and Katp channels are true, ketone metabolism should boost Katp and 
reduce ASIC conductance, antagonizing hyperexcitability. Furthermore, the anaerobic 
glycolytic byproduct lactate increases extraneuronal prostaglandin E2 through the 
inhibition of prostaglandin transporters in astrocytes (Carmignoto & Gómez-Gonzalo, 
2010). Prostaglandins are immunological vasodilators that also promote the formation of 
platelet-aggregating thromboxane A2, worsening the prospect of neuronal clot dissolution 
(“Stroke Prevention | Internet Stroke Center,” n.d.).  
 KDs are also thought to lower brain-derived neurotropic factor (BDNF) levels, 
either through elevation of poly-unsaturated levels of fatty acids, or through depression of 
glucose concentrations. Although BDNF is generally considered to be neuroprotective 
and stimulate neurogenesis, it has also been shown to be pro-epileptic. For example, 
developmental knockout of the BDNF receptor TrkB has eliminated epileptic symptoms 
altogether in certain models (McNamara & Scharfman, 2012). This could be BDNF’s 
role of potentiating glutamate receptor function by promoting phosphorylation of 
excitatory NMDA receptor type 1 on residue Ser-897 (Slack, Pezet, McMahon, 
Thompson, & Malcangio, 2004). This could also be because BDNF promotes expression 
of excitatory glutamate receptors type 1 and 2 (Caldeira et al., 2007). BDNF synthesis is 
partly regulated by levels of cytosolic NADH. Higher levels of glycolysis result in higher 
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levels of cytosolic NADH, higher BDNF, and a higher probability of seizure. Because 
KDs reduce glycolysis, they should reduce BDNF levels, and reduce excitability.  
Even if the proposed mechanisms are incorrect, KDs have been shown to exhibit 
neuroprotective effects in vitro, in vivo, and in a few clinical studies. For example, the 
administration of AcAc infusion for 14 days to both in vitro and in vivo rodent models of 
glutamate-induced neurotoxicity resulted in decreased neuronal damage (32%), reduced 
lesion volume (50%), and improved cellular ATP (Massieu et al, 2003). Although 
relatively sparse, the existing clinical data suggests that KDs warrant future research for 
neurodegenerative conditions, neurotraumatic injuries (Davis et al., 2008), and any other 
condition in which brain metabolism may be altered. (Krikorian et. al, 2012). For 
example, one study used intravenous ß-OHB to reduce severity of symptoms in patients 
diagnosed with Alzheimer’s disease by increasing paragraph recall accuracy relative to 
control subjects (Reger et al., 2004). However, clinical data also document physical 
complications such as elevated total cholesterol, LDL cholesterol, and TG levels, all of 
which need to be considered and weighed against neuroprotective benefits in a clinical 
setting (Güzel, Yılmaz, Uysal, & Arslan, 2015).  
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OBJECTIVES 
 
The objective of this paper is to investigate a potential relationship between ketogenic 
diets and cerebral excitability. Specifically, we will:  1. Compare the electroencephalogram (EEG) from animals exposed to a ketogenic 
diet with those exposed to a control diet. EEG measurements will be made in the 
parietal cortex of anesthetized animals, and evaluated using power spectral 
density estimates.  	
2. Evaluate potential alterations in excitability after non-invasive induction of a 
stroke event. 
 
Throughout this study, we will test the hypothesis that the presence of the ketogenic diet 
produces alterations in cerebral excitability. 
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METHODS 	
Subjects: 
Male Sprague-Dewey rats, (n=20, 385-490g) were used in these experiments.  
Animals arrived and were given one week to acclimate to their new housing environment 
prior to implementation of their specific diets. The housing environment was temperature 
maintained between 70-74 degrees Fahrenheit with 12:12 hour light-dark cycle, lights 
turning on at 6 am and off at 6 pm. After the acclimation period, all rats were fasted for 
18 hours to stabilize the concentrations of blood glucose, and initiate a state of 
ketogenesis (Puchowicz et al., 2008).  All procedures were conducted in strict accordance 
with the Institutional Animal Care and Use Committee of Boston University’s approved 
guidelines. 
 
Diet Manipulation 
Rats were randomly and evenly assigned to either an ketogenic or irradiated 
ingredient-matched control diet group, both of which were fed ad libitum for a minimum 
of three weeks prior to experimentation. The ketogenic diet was formulated with a 
fat:protein+carbohydrate ratio of approximately 4.2 and provides 6.7kcal/gram, while the 
control diet has a fat:protein+carbohydrate ratio of approximately .06 and provides 3.6 
kcal/gram. Both diets were irradiated prior to incorporation. The control diet provided 
77% of calories from carbohydrate, with the caloric remainder being equally split 
between fat and protein, a ratio designed to mimic a classic Western diet. Both diets were 
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obtained from Envigo Teklad Diets, with formulation assistance from nutrition expert Dr. 
Tina Herfel. The macronutrient, micronutrient and ingredient source breakdowns are 
listed in table 3 below. The KD was fed by filling petri dishes with the feed, with care 
taken to place the dish above their bedding. Diet was replaced daily to avoid 
contamination of the feed with kicked-up bedding.  
Rats were paired-housed. Because pair-housing may result in bullying particularly 
with dietary manipulation weights were monitored daily for disparities between cage 
partners. None were observed.  
 
Table 3: Macronutrient and micronutrient breakdown of Envigo Teklad diets 
utilized.  
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Animals were weighed immediately prior to experimentation, and subsequently 
anesthetized with sodium pentobarbital (40mg/kg) and chloral hydrate (160mg/kg). 
Glycopyrolate (0.02mg/kg) was injected to reduce respiratory secretions.  
Once the animal was non-responsive to a tail pinch, tail vein catheterization was 
performed. Following successful catheterization, the animal was placed in a rodent 
stereotaxic apparatus (Kopf instruments, Tujunga, CA) to ensure immobility of the 
cranium. A midline incision was made, and skin and fascia were reflected to expose the 
frontal, parietal and occipital bones. 
 
Recording Electrode Placements:   
Twelve animals (6 control, 6 ketogenic) underwent electrophysiological 
monitoring of the hemisphere contralateral to the stroke. A hole in the skull was drilled 
0.5mm anterior, and +3.5mm lateral of lambda to introduce a multicontact recording 
electrode into the brain. Drilling was performed with a saline wash to prevent heating of 
the bone. Two more drill sites were marked above and below the landmark bregma, 
halfway between midline and the right edge of the fascia. These became the sites of the 
indifferent and ground electrodes. An additional five animals underwent the same 
procedure, except the recording electrode was placed on the same side of the lesion. 
A 23-channel recording electrode with 75-micron electrode spacing (Plexon) was 
used to simultaneously record brain signals from throughout the neocortical layers. The 
recording electrode apparatus was connected to the ground leads, and all were connected 
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to a headstage preamplifier that was connected to the main amplifier (Neurotrack 
systems; Ulbert et al., 2001).  
 
Focal Ischemic lesion:  
After placement of the recording electrode, a fiber optic light was placed flush 
and perpendicular to the skull. The light was placed on the left rostral parietal bone.  
Forty-five minutes after placement of the recording electrode, five 5-minute long baseline 
recordings were made.  The data collected from the electrode was registered and saved on 
the computer using a custom-made program on National Instruments LabVIEW software. 
Thereafter, a 7-minute recording was initiated, during which all room lights were turned 
off, the fiber optic white light was turned on, and 0.5ml of Rose Bengal was slowly 
injected into the tail catheter with a 2ml flush of saline. The interaction of the light with 
the intravascular Rose Bengal produced a photothrombic stroke with associated cortical 
spreading depression, the latter of which could be visualized from the recorded EEG. 
Following the stroke event, 1 hour of recordings were conducted in 5-minute intervals for 
contralateral animals, and 2 hours of recording for ispilateral animals. 
Upon completion of the experiment, the rat was given a lethal dose of 
pentobarbital and intracardially perfused with approximately 500mL of 4% 
paraformaldehyde in 0.1M phosphate buffer, pH=7.4.  Sodium nitrate and heparin were 
administered prior to the fixative. After the fixation, the brain was post-fixed in 4% 
paraformaldehyde. 
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Analysis: 
The first area of focus for this study revolved around potential differences in 
neuronal excitability between KD and control rats. For this component of the study, 
contralateral recordings were used. To determine if there were differences in basal 
excitability, we evaluated frequency content by performing a multitaper spectrogram on 
the input voltage signals. For this analysis, the power spectral density for each channel 
was estimated during each file over specific frequency values and plotted. Multitaper 
estimates were performed using a time-bandwidth product of 3, and 5 tapers over a 
frequency range of 0 to 80Hz. The resulting power spectra vectors were then averaged 
across animals for the appropriate time and frequencies. Values were normalized and 
subsequently evaluated for statistical significance.   
The second analysis utilized current source density analysis (CSD, Pettersen et al., 
2007) of the coincident voltage signals from the recording electrode to evaluate the 
presence of a cortical spreading depression. The electrostatic forward solution was 
calculated using a spline smoothing to generate the current source density estimate. The 
number of waves and their timing was counted. This method of analysis allowed for 
spatiotemporal visualization of outward and inward current flow from an extracellular 
perspective, while factoring out currents not in the immediate vicinity of the recording 
electrode. 
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RESULTS 	
Table 4: Record of animal data for experiments. Contralateral measurement for Drill 
site:  + 0.5mm from lambda, +3.5mm from lambda, measured using controller arm on the 
left sided stereotaxic placement. Ipsilateral measurements for drill site: + 0.5mm from 
lambda, +3.5mm from lambda, measured using controller arm on the right sided 
stereotaxic placement. Location of white optic light: just inferior and left to bregma..  
 
Date	 Rat	 Type		
Weight	
(g)	 Notes		
Stroke	
time	
Low	
frequency	
dips	
observed	
2.2.16	 137	 Control	 410	 Contralateral	 7min	 1	
2.3.16	 138	 Control	 385	 Contralateral		 7min	 4	
2.5.16	 139	 Keto	 430	 Contralateral		 7min	 10	
2.7.16	 140	 Keto	 435	 Contralateral		 7min	 7	
2.9.16	 141	 Keto	 470	 Contralateral		 7min	 5	
2.10.16	 142	 Keto	 450	 Contralateral		 7min	 12	
2.10.16	 143	 Keto	 460	 Contralateral		 7min	 2	
2.11.16	 144	 Keto	 430	 Contralateral		 7min	 3	
2.16.16	 150	 Control	 470	 Contralateral		 7min	 2	
2.19.16	 152	 Control	 480	 Contralateral		 7min	 1	
2.19.16	 153	 Control	 470	 Contralateral		 7min	 5	
2.20.16	 154	 Control	 460	 Contralateral		 7min	 6	
2.21.16	 155	 Control	 460	 Contralateral		 7min	 5	
2.22.16	 156	 Control	 465	 Ipsilateral	 7min	
	2.23.16	 157	 Control	 460	 Ipsilateral	 7min	
	2.23.16	 158	 Control	 470	 Ipsilateral	 10min	
	2.24.16	 159	 Control	 490	 Ipsilateral	 10min	
	2.24.16	 160	 Control	 490	 Ipsilateral	 10min	
	2.6.16	 failed	 Keto	 	430	 Contralateral		
	
	
2.7.16	 failed	 Keto	 	440	 Contralateral		
	
		
2.8.16	 failed	 Keto	 	465	 Contralateral		
	
		
2.8.16	 failed	 Keto	 	470	 Contralateral		
	
		
2.9.16	 failed	 Keto	 	460	 Contralateral		
	
		
2.12.16	 failed	 keto	 	460	 Contralateral		
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Animal Data	
Animals were weighed immediately prior to experimentation. Mean weight for 
controls was 459.2g with a SD=30.5, and mean weight for ketogenic animals was 445.8g, 
with a SD=16.85. There was no statistically significant difference in mean weights 
between animals. Approximately 2 weeks into the feeding period, the KD animals 
developed porphyrin secretions on and around their eyes and noses. These secretions are 
associated with stress or allergies in rats. We hypothesized that due to the soft nature of 
their diet, they were unable to grind their teeth down or chew on anything, and were 
developing the secretions as a result. Irradiated wood blocks were placed into their cages 
to gnaw on, which seemed to improve symptoms.  
 
Experimental consideration 
 During the experiments, each animal was sedated and anesthetized. As indicated 
by table 1, a disproportionate number of animals in the ketogenic group exhibited 
premature death from the anesthetic prior to experimentation. While it is clear that the 
ketogenic group was evaluated earlier than the control diet animals and this effect could 
be a result of practice and experience, it is also worth considering that the animals 
subjected to a ketogenic diet may have had a differential susceptibility to the anesthetic. 
 
	26 
Power analysis 
We hypothesized that ketogenic diets would alter basal neuronal excitability 
metrics compared to controls. To evaluate this hypothesis, averages and standard errors 
for power spectra were calculated and averaged for each epoch across frequency values. 
Results are depicted in figure 6. 
 
Figure 6: Power averages across recordings across frequencies. Frequencies bands 
were split into two groups to better visualize the power for alpha, beta and gamma bands. 
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There was high variance in measures between animals, and t-tests revealed no 
significant differences in any of the comparisons. P values for t-tests of raw averages of 
delta, theta, alpha, beta gamma, and total power values were .506, .331, .307, .309, .538, 
and .831 respectively. To reduce standard error, data were normalized, and then evaluated 
again with t-tests. P values for normalized delta, theta, alpha, beta and gamma 
frequencies were .338, .520, .537, .427, and .830 respectively. A visual representation of 
the normalized power averages across frequency bands is shown in figure 6. 
This suggests that there are no differences in basal excitability metrics between 
ketogenic and control-diet fed animals. These estimates of EEG power were generated 
for 5-7 minute blocks.   
 Excitability was also examined at a finer time course by generating and evaluating 
spectrograms. These spectrograms were characterized by a high power at low 
frequencies, which became lower at higher frequencies. In both groups, spectrograms 
revealed temporary reductions in power at low frequencies  (0-30Hz). These events were 
referred to as dips. Dips were present in delta (0.1-3Hz), theta (4-7Hz), alpha (8-15Hz), 
and beta (16-31Hz) ranges. An example of the dip is pictured in figure 7 at epochs 24 and 
27. Dips were counted and totaled for all KD and control contralateral animals, and were 
statistically evaluated using chi-square analysis. Two different chi-squares were 
conducted, one with expected dip occurrence values equal to those observed for control 
experiments, and another with expected values equal to the average between control and 
ketogenic experiments. The chi-square for both conditions were statistically significant, 
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the first with a p<.05(p=.001) for 1 degree of freedom, and the second with a p<.05 
(p=.008) 
The primary EEG recording data was used to assess what these low frequency 
dips represented. As shown in figure 7 on the following page, the dip on the spectrogram 
corresponded to a period of EEG depression. The compressed EEG data shows an 
absence of any precipitating event for this depression. This suggests that ketogenic diets 
produced more acute periods of hypoactivity than did controls, but the basis for this is 
unclear.  
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Figure 7: Low frequency dip data. Primary EEG data (bottom) that corresponds to the 
low frequency dip visualized in the power spectra (top). Depressed EEG activity was 
consistently seen during dip time intervals. 
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Current source density analysis 
Current source density analysis was performed on EEG recordings for 
contralateral and ispilateral animals. Plots were made, which allowed for the 
spatiotemporal visualization of ion flow in the cortex following induction of stroke.  
In one animal, recordings were made ipsilateral to the stroke.  Two CoSDs within 
this animal were visualized using current source density, one of which is pictured below 
in figure 8. The events occurred approximately 33 and 80 minutes after the stroke was 
induced. There were no CoSDs were visualized in any of the contralateral current source 
density plots. 
 
Figure 8: CSD plot showing CoSD in ispilateral pilot approximately 33 minutes 
after induction of stroke ended. Blue represents a current source, and red indicates a 
current sink.  
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Frequency analysis was conducted at the same time points for the successful 
ispilateral experiment. As observed below, low frequency amplitude was reduced prior to 
the onset of CoSD on the EEG by a margin of approximately 100 seconds. This served as 
a standard for comparison against other power spectra. No power spectra for other 
animals showed similar changes in low-frequency amplitudes over time.  
 
Figure 9: Ipsilateral CoSD data. On top, a CoSD event is visualized in EEG data. On 
bottom, the same CoSD event is boxed. There was a smooth depression in low-frequency 
power (red) approximately 100 seconds prior to the CoSD event. 
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DISCUSSION 
Results 
	
This study found no alteration in excitability in the ketogenic diet group relative 
to the control group.  While an increase in the number of ‘dips’ in the ketogenic group 
was observed, they were not due to transient spreading depression events. Because of 
this, the basis of this difference is unclear. As a positive control for cortical spreading 
depression measurements, a recording ispilateral to the site of stroke was conducted. This 
experiment measured two cortical spreading depression events. 
 
Stroke, Cortical Spreading Depression, and Hyperexcitability 
 There are several metrics that were used to assess for diet-induced changes in 
cerebral excitability. The first involved power spectral density analysis to evaluate 
baseline levels of cerebral excitability. Another involved monitoring cerebral activity 
contralateral to a stroke. During a stroke, it is believed that the contralateral hemisphere 
becomes more excitable for up to 1 week (Johansson, 2000). Also coincident with stroke 
are phenomena known as Cortical Spreading Depressions (CoSDs) and peri-infarct 
depolarizations (PIDs). CoSD immediately follows brain injury, ischemic stroke, 
subarachnoid and intracranial hemorrhage, and is believed to be associated with the aura 
of migraines (Lauritzen et al., 2011). Because these phenomena alter cerebral excitability, 
it was also of interest to test if the low frequency dips observed in the spectrograms were 
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associated with, or were precipitated by CoSD or PIDs that spread to the contralateral 
hemisphere. 
CoSD occurs due to failure of ion gradient maintenance in the brain. This failure 
propagates as a wave through cortical gray matter at a rate of 2-5mm/min, transiently 
interrupting function of the cortex (Lauritzen et al., 2011). In the wake of CoSD, neurons 
become hyperpolarized and hypoexcitable for a prolonged period of time, which is 
visually confirmed through depressed EEG activity. Glucose consumption, glutamate 
transmission, and ion flux is increased during CoSDs, with profound extracellular K+ 
accumulation (Enger et al., 2015). Peri-infarct depolarizations are waves that induce the 
same effects as CoSD, but which are caused specifically from ischemic events (Fabricius 
et al., 2006). These waves begin in tissue directly adjacent to the ischemic core, or the 
penumbra. Recurrent PIDs in the injured brain are associated with increased cell death 
(Busch, Gyngell, Eis, HoehnBerlage, & Hossmann, 1996). The reestablishment of ion-
gradients is energetically expensive as mentioned previously. Without oxygen and 
adequate perfusion, PIDs increase in frequency, and tissue damage worsens (Fabricius et 
al., 2006). 
 
Limitations:  
There are several limitations with this study. A major limitation is the small 
sample size, which hampers statistical power and the validity of our results. Secondly, the 
study was conducted in rats. Although many similarities between rat and human brain 
structure and function exist, there are important differences that limit the conclusions of 
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metabolic studies of this nature. It has been shown that MCT-1 and MCT-2 density 
decreases over time for rats, and that even for young rats, the brain dependence on ketone 
bodies is relatively less than it is for humans (Prins, 2008). It is unclear if ketogenic 
metabolism would be as beneficial in rats as it would be in humans, and more research 
needs to be done on this. Clinical data are sparse for ketogenic diets, although some 
studies do show promising results for patients with Alzheimer’s and intractable epilepsy. 
 Another consideration is that oxygen is still required for the electron transport 
chain. Even if KDs do funnel metabolic substrates into the citric acid cycle more 
efficiently than glucose metabolism, without oxygen, electron acceptor recycling 
necessary for the TCA cycle and ETC will be impaired. Because of this, the conclusions 
we draw for KD may not apply to all neurological diseases, and should be considered 
mainly in light of stroke. 
 
Confounds:  
There are several confounds within this experiment. Un-blinded execution and 
analysis of experiments may have accounted for a large source of bias. Because KD 
experiments were completed prior to the control experiments, the experimenter likely 
became more proficient with experimental techniques over time. This may mean that 
later recordings were more reliable. 
Food rations were intended to be ad-libitum, but rationing of the KD had to be 
utilized 3 weeks after feeding started due to limited supplies. As the KD had a frosting-
like consistency, care was taken to place the diet-filled petri dishes above the animal’s 
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bedding. Still, animals would kick bedding into the petri dishes, which made accurate 
monitoring of accessible food difficult. Animal weights were taken daily to assess for 
disparities, and to ensure that KD animals were gaining weight at a similar rate to 
controls. Although age did differ between ketogenic and control animals by 
approximately 12-24 days at the onset of experimentation, there is no precedent for 
believing that this would have a significant effect upon ketogenic metabolism. 
 
Improvements:  
In regards to the experimental methods, some improvements could be made.  
Staggered feeding could have been utilized from the beginning of the study. Staggering 
the feeding start times would provide more consistency between animals for time spent 
on a diet, improve strength of conclusions surrounding metabolic changes, and preserve 
diet stores.  
Ipsilateral recordings for rats 157 through 160 were conducted with a damaged 
recording electrode, which likely accounts for the absence of observed CoSD during 
analysis of these animals.  
 
Conclusions: 
Analysis of power spectra averages across animals showed no differences in basal 
excitability between the two groups. Variability was high between and within recording 
and no significance could be attributed to differences in average power data between 
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animal groups. When the measures were normalized to total power, there were still no 
detected differences. This finding supports several other studies that also show no 
changes in basal excitability in rat models (Blaise, Ruskin, Koranda, & Masino, 2015) 
 However, there was a statistically significant difference (p<.01) in the number of 
low-frequency dips amongst contralateral recordings. As noted in the results portion of 
this paper, the dips in frequency were associated with periods of EEG hypoactivity. This 
implies that ketogenic diets produced more acute periods of hypoactivity than did 
controls. It is also possible that these dips represent short-lived spreading depression 
events. To that end, current source density analysis was performed to determine whether 
spontaneous spreading depression events were the cause. Current source density analysis 
showed no cortical spreading depression events in either control or ketogenic 
contralateral recordings. Since no spreading depression events were measured, and since 
the primary data revealed the lack of any discrete explanatory event, there is no 
explanation for this finding. 
Future research:  
This research found no obvious differences in basal excitability, a finding 
consistent with data that showed that animals exposed to a ketogenic diet did not differ 
from controls based on excitability measures or paired-pulse measures, but did exhibit a 
decrease in synaptic potentiation in the hippocampus (Blaise et al., 2015). The next step 
in this research would be to evaluate whether such a discrepancy is the case in the 
cerebral cortex by evaluating paired pulse and synaptic potentiation measures. Moreover, 
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it would be very useful to evaluate whether the induction of stroke was delayed or 
potentiated with a ketogenic diet by recording ipsilaterally to the stroke. 
Immunohistochemical studies can be performed on the brains gathered from this 
experiment to investigate differences in neuronal populations between groups. It is 
unclear whether glutaminergic and GABAergic respond similarly to changes in 
metabolism, and specific stains could provide valuable information to that question.  
Because changes in contralateral hemisphere activity following stroke have not be 
well characterized, it is worthwhile to continue analysis of the primary EEG data. Focus 
should remain on changes in frequency and amplitude of contralateral EEG activity 
during stroke. The cellular changes concurrent with the observed dips should also be 
characterized. It is possible that these dips correspond to metabolic insufficiency without 
associated CoSD, and should be evaluated further. 
Additionally, some studies have evaluated the influence of KD on hippocampal 
frequencies above 150Hz (Simeone, Samson, Matthews, & Simeone, 2014). It is possible 
that our design missed valuable information about neuronal frequency changes in the 
150-200Hz range. Future studies could extend the frequency ranges, and the location of 
brain recording. 
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